In this study, we investigated the major subgroup of GBMs that do not have the glioma-CpGs island methylator phenotype (G-CIMP), which is exclusively featured by the absence of isocitrate dehydrogenase (IDH) mutations (mostly IDH1R132H) [9]. This evidence concerns the gene IDH1 and glioma.